Buchumschlag

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

The enhancer of zeste homolog 2 (EZH2) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association between EZH2 expression and prognosis in patients with renal cell carcinoma (RCC).

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wagener, Nina (VerfasserIn) , Macher-Göppinger, Stephan (VerfasserIn) , Pritsch, Maria (VerfasserIn) , Hüsing, Johannes (VerfasserIn) , Hoppe-Seyler, Karin (VerfasserIn) , Schirmacher, Peter (VerfasserIn) , Pfitzenmaier, Jesco (VerfasserIn) , Haferkamp, Axel (VerfasserIn) , Hoppe-Seyler, Felix (VerfasserIn) , Hohenfellner, Markus (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 4 Oct 2010
In: BMC cancer
Year: 2010, Jahrgang: 10, Pages: 1-10
ISSN:1471-2407
DOI:10.1186/1471-2407-10-524
Online-Zugang:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1186/1471-2407-10-524
Verlag, kostenfrei, Volltext: https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-524
Volltext
Verfasserangaben:Nina Wagener, Stephan Macher-Goeppinger, Maria Pritsch, Johannes Hüsing, Karin Hoppe-Seyler, Peter Schirmacher, Jesco Pfitzenmaier, Axel Haferkamp, Felix Hoppe-Seyler, Markus Hohenfellner
Beschreibung
Zusammenfassung:The enhancer of zeste homolog 2 (EZH2) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association between EZH2 expression and prognosis in patients with renal cell carcinoma (RCC).
Beschreibung:Gesehen am 27.09.2023
Beschreibung:Online Resource
ISSN:1471-2407
DOI:10.1186/1471-2407-10-524

Ähnliche Einträge